204 related articles for article (PubMed ID: 25863422)
1. Prognostic value of serial B-type natriuretic peptide measurement in transcatheter aortic valve replacement (from the PARTNER Trial).
O'Neill BP; Guerrero M; Thourani VH; Kodali S; Heldman A; Williams M; Xu K; Pichard A; Mack M; Babaliaros V; Herrmann HC; Webb J; Douglas PS; Leon MB; O'Neill WW
Am J Cardiol; 2015 May; 115(9):1265-72. PubMed ID: 25863422
[TBL] [Abstract][Full Text] [Related]
2. Elevation of B-Type Natriuretic Peptide at Discharge is Associated With 2-Year Mortality After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: Insights From a Multicenter Prospective OCEAN-TAVI (Optimized Transcatheter Valvular Intervention-Transcatheter Aortic Valve Implantation) Registry.
Mizutani K; Hara M; Iwata S; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710182
[TBL] [Abstract][Full Text] [Related]
3. Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation.
López-Otero D; Trillo-Nouche R; Gude F; Cid-Álvarez B; Ocaranza-Sanchez R; Alvarez MS; Lear PV; Gonzalez-Juanatey JR
Int J Cardiol; 2013 Sep; 168(2):1264-8. PubMed ID: 23280329
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of B-type natriuretic peptide to predict outcome of patients treated by transcatheter aortic valve implantation.
Kefer J; Beauloye C; Astarci P; Renkin J; Glineur D; Dekleermaeker A; Vanoverschelde JL
Am J Cardiol; 2010 Dec; 106(12):1782-6. PubMed ID: 21055712
[TBL] [Abstract][Full Text] [Related]
5. Impact of Preprocedural B-Type Natriuretic Peptide Levels on the Outcomes After Transcatheter Aortic Valve Implantation.
Abramowitz Y; Chakravarty T; Jilaihawi H; Lee C; Cox J; Sharma RP; Mangat G; Cheng W; Makkar RR
Am J Cardiol; 2015 Dec; 116(12):1904-9. PubMed ID: 26602075
[TBL] [Abstract][Full Text] [Related]
6. Effect of B-type natriuretic peptides on long-term outcomes after transcatheter aortic valve implantation.
Koskinas KC; O'Sullivan CJ; Heg D; Praz F; Stortecky S; Pilgrim T; Buellesfeld L; Jüni P; Windecker S; Wenaweser P
Am J Cardiol; 2015 Nov; 116(10):1560-5. PubMed ID: 26428025
[TBL] [Abstract][Full Text] [Related]
7. B-type natriuretic peptide is a strong independent predictor of long-term outcome after transcatheter aortic valve implantation.
Gotzmann M; Czauderna A; Aweimer A; Hehnen T; Bösche L; Lind A; Kloppe A; Mügge A; Ewers A
J Heart Valve Dis; 2014 Sep; 23(5):537-44. PubMed ID: 25799701
[TBL] [Abstract][Full Text] [Related]
8. Impact of pre-procedural serum albumin levels on outcome of patients undergoing transcatheter aortic valve replacement.
Koifman E; Magalhaes MA; Ben-Dor I; Kiramijyan S; Escarcega RO; Fang C; Torguson R; Okubagzi P; Negi SI; Baker NC; Minha S; Corso PJ; Shults C; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2015 May; 115(9):1260-4. PubMed ID: 25759105
[TBL] [Abstract][Full Text] [Related]
9. Impact of B-type natriuretic peptide on short-term clinical outcomes following transcatheter aortic valve implantation.
O'Sullivan CJ; Stortecky S; Heg D; Jüni P; Windecker S; Wenaweser P
EuroIntervention; 2015 Feb; 10(10):e1-8. PubMed ID: 24429160
[TBL] [Abstract][Full Text] [Related]
10. B-type natriuretic peptide is associated with remodeling and exercise capacity after transcatheter aortic valve replacement for aortic stenosis.
Sato K; Kumar A; Krishnaswamy A; Mick S; Desai MY; Griffin BP; Kapadia SR; Popović ZB
Clin Cardiol; 2019 Feb; 42(2):270-276. PubMed ID: 30565264
[TBL] [Abstract][Full Text] [Related]
11. Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve).
Williams M; Kodali SK; Hahn RT; Humphries KH; Nkomo VT; Cohen DJ; Douglas PS; Mack M; McAndrew TC; Svensson L; Thourani VH; Tuzcu EM; Weissman NJ; Kirtane AJ; Leon MB
J Am Coll Cardiol; 2014 Apr; 63(15):1522-8. PubMed ID: 24561149
[TBL] [Abstract][Full Text] [Related]
12. Different impact of aortic regurgitation assessed by aortic root angiography after transcatheter aortic valve implantation according to baseline left ventricular ejection fraction and N-terminal pro-B-type natriuretic peptide.
Kaneko H; Hoelschermann F; Schau T; Tambor G; Neuss M; Butter C
Cardiovasc Interv Ther; 2018 Jul; 33(3):232-238. PubMed ID: 28567700
[TBL] [Abstract][Full Text] [Related]
13. Interplay between mitral regurgitation and transcatheter aortic valve replacement with the CoreValve Revalving System: a multicenter registry.
Bedogni F; Latib A; De Marco F; Agnifili M; Oreglia J; Pizzocri S; Latini RA; Lanotte S; Petronio AS; De Carlo M; Ettori F; Fiorina C; Poli A; Cirri S; De Servi S; Ramondo A; Tarantini G; Marzocchi A; Fiorilli R; Klugmann S; Ussia GP; Tamburino C; Maisano F; Brambilla N; Colombo A; Testa L
Circulation; 2013 Nov; 128(19):2145-53. PubMed ID: 24088530
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).
Elmariah S; Palacios IF; McAndrew T; Hueter I; Inglessis I; Baker JN; Kodali S; Leon MB; Svensson L; Pibarot P; Douglas PS; Fearon WF; Kirtane AJ; Maniar HS; Passeri JJ;
Circ Cardiovasc Interv; 2013 Dec; 6(6):604-14. PubMed ID: 24221391
[TBL] [Abstract][Full Text] [Related]
15. Correlation of brain natriuretic peptide levels in patients with severe aortic stenosis undergoing operative valve replacement or percutaneous transcatheter intervention with clinical, echocardiographic, and hemodynamic factors and prognosis.
Ben-Dor I; Minha S; Barbash IM; Aly O; Dvir D; Deksissa T; Okubagzi P; Torguson R; Lindsay J; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2013 Aug; 112(4):574-9. PubMed ID: 23683951
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve).
Dvir D; Waksman R; Barbash IM; Kodali SK; Svensson LG; Tuzcu EM; Xu K; Minha S; Alu MC; Szeto WY; Thourani VH; Makkar R; Kapadia S; Satler LF; Webb JG; Leon MB; Pichard AD
J Am Coll Cardiol; 2014 Jan; 63(3):269-79. PubMed ID: 24140659
[TBL] [Abstract][Full Text] [Related]
17. Association of Natriuretic Peptide Levels After Transcatheter Aortic Valve Replacement With Subsequent Clinical Outcomes.
O'Leary JM; Clavel MA; Chen S; Goel K; O'Neill B; Elmariah S; Crowley A; Alu MC; Thourani VH; Leon MB; Pibarot P; Lindman BR
JAMA Cardiol; 2020 Oct; 5(10):1113-1123. PubMed ID: 32667623
[TBL] [Abstract][Full Text] [Related]
18. B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival.
Clavel MA; Malouf J; Michelena HI; Suri RM; Jaffe AS; Mahoney DW; Enriquez-Sarano M
J Am Coll Cardiol; 2014 May; 63(19):2016-25. PubMed ID: 24657652
[TBL] [Abstract][Full Text] [Related]
19. Recovery after balloon aortic valvuloplasty in patients with aortic stenosis and impaired left ventricular function: predictors and prognostic implications.
Kefer J; Gapira JM; Pierard S; De Meester C; Gurne O; Chenu P; Renkin J
J Invasive Cardiol; 2013 May; 25(5):235-41. PubMed ID: 23645048
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]